Terms: = Skin cancer AND AMER1, RP11-403E24_2, 139285, FAM123B, ENSG00000184675, FLJ39827, WTX AND Treatment
22037 results:
1. Voriconazole metabolism is associated with the number of skin cancers per patient.
Ike JI; Smith IT; Mosley D; Madden C; Grossarth S; Halle BR; Lewis A; Mentch F; Hakonarson H; Bastarache L; Wheless L
Arch Dermatol Res; 2024 May; 316(6):303. PubMed ID: 38819581
[TBL] [Abstract] [Full Text] [Related]
2. From decision to reflection: understanding the experiences and unmet care needs of patients treated with immunotherapy for melanoma in the adjuvant or metastatic setting.
Kamminga NCW; van der Veldt AAM; Wakkee M; van den Berge FR; van der Beek LAA; Joosen MCW; Joosse A; de Joode K; Nijsten TEC; Lugtenberg M
BMC Cancer; 2024 May; 24(1):662. PubMed ID: 38816701
[TBL] [Abstract] [Full Text] [Related]
3. [Research hotspots and frontiers of Realgar based on CiteSpace knowledge graph analysis].
Wu FZ; Wang MJ; Lyu Y; Fu JH; Hu XM
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2532-2543. PubMed ID: 38812149
[TBL] [Abstract] [Full Text] [Related]
4. Case report: Durable complete response of a mucosal melanoma of the rectum after neoadjuvant immunotherapy with ipilimumab plus nivolumab.
Krueger O; Eisenburger R; Tasdogan A; Zimmer L; Livingstone E; Hadaschik E; Theurer S; Brodin B; Schadendorf D; Ugurel S
Front Immunol; 2024; 15():1369190. PubMed ID: 38807589
[TBL] [Abstract] [Full Text] [Related]
5. Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study.
Fleischmann R; Swierkot J; Penn SK; Durez P; Bessette L; Bu X; Khan N; Li Y; Peterfy CG; Tanaka Y; Mysler E
RMD Open; 2024 May; 10(2):. PubMed ID: 38806190
[TBL] [Abstract] [Full Text] [Related]
6. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
[TBL] [Abstract] [Full Text] [Related]
7. Radiofrequency treatment Attenuates Age-Related Changes in Dermal-Epidermal Junctions of Animal skin.
Byun KA; Kim HM; Oh S; Batsukh S; Son KH; Byun K
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791217
[TBL] [Abstract] [Full Text] [Related]
8. Silver Complexes of Miconazole and Metronidazole: Potential Candidates for Melanoma treatment.
Fabijańska M; Rybarczyk-Pirek AJ; Dominikowska J; Stryjska K; Żyro D; Markowicz-Piasecka M; Szynkowska-Jóźwik MI; Ochocki J; Sikora J
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791121
[TBL] [Abstract] [Full Text] [Related]
9. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of Acute Toxicities, Overall treatment Time and Quality of Life in Head and Neck cancer Patients Treated with IMRT and Helical Tomotherapy.
R YB; Swamy K; Swaroopa C; Maiya V
Gulf J Oncolog; 2024 May; 1(45):7-14. PubMed ID: 38774928
[TBL] [Abstract] [Full Text] [Related]
11. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
[TBL] [Abstract] [Full Text] [Related]
12. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
[TBL] [Abstract] [Full Text] [Related]
13. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
14. Subminute thermal damage to cell types present in the skin.
Doppegieter M; van Leeuwen TG; van Weert A; Aalders MCG; Bakker ENTP
Int J Hyperthermia; 2024; 41(1):2354435. PubMed ID: 38754976
[TBL] [Abstract] [Full Text] [Related]
15. Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic Therapy.
Mørk E; Mjønes P; Foss OA; Mørk C; Bachmann IM; Kroon S; Dotterud LK; Helsing P; Vatne Ø; Christensen E
Acta Derm Venereol; 2024 May; 104():adv18308. PubMed ID: 38751175
[TBL] [Abstract] [Full Text] [Related]
16. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract] [Full Text] [Related]
17. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract] [Full Text] [Related]
18. First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.
D'Angelo SP; Lebbé C; Mortier L; Brohl AS; Fazio N; Grob JJ; Prinzi N; Hanna GJ; Hassel JC; Kiecker F; von Heydebreck A; Güzel G; Nghiem P
ESMO Open; 2024 May; 9(5):103461. PubMed ID: 38744102
[TBL] [Abstract] [Full Text] [Related]
19. Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17-year retrospective study.
Amonchaisakda N; Rujitharanawong C; Tuchinda P; Kulthanan K; Chularojanamontri L
Exp Dermatol; 2024 May; 33(5):e15095. PubMed ID: 38742822
[TBL] [Abstract] [Full Text] [Related]
20. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
Stoyukhina AS
Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
[TBL] [Abstract] [Full Text] [Related]
[Next]
